Skip to content

An Observational Study on Treatment Compliance by Children Treated With Growth Hormone

IMprove PAtient Compliance sTudy: An Observational, Cross-sectional Study on Children Treated With Growth Hormone in France

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01068639
Acronym
IMPACT
Enrollment
0
Registered
2010-02-15
Start date
2010-02-28
Completion date
2010-04-30
Last updated
2014-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Growth Hormone Deficiency in Children, Growth Hormone Disorder

Brief summary

This study is conducted in Europe. This observational study aims at evaluating compliance with growth hormone treatment in children and identifying factors influencing compliance.

Interventions

BEHAVIORALNo treatment given

No treatment given to study participants, only behaviorial patterns with respect to treatment compliance is observed.

Sponsors

Novo Nordisk A/S
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Child treated for at least one year with growth hormone any growth hormone product * Followed by the participating paediatrician for at least 1 year.

Exclusion criteria

* Refusal to participate * Child and/or parent unable to give consent or fill out the questionnaires * Child participating in a therapeutic trial

Design outcomes

Primary

MeasureTime frame
Average number of injections omitted during the previous monthmeasured over the past 2 months (retrospective data collection)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026